Company Filing History:
2 out of 975 
2 out of 5,463 
Years Active: 2020-2023
Title: Innovations by Caurnel Morgan
Introduction
Caurnel Morgan is an accomplished inventor based in College Station, Texas. He has made significant contributions to the field of medical science, particularly in the treatment of depression and anxiety disorders. With two patents to his name, Morgan's work focuses on innovative approaches to mental health treatment.
Latest Patents
Morgan's latest patents include "Modulators of melanocortin receptors for the treatment of depression and anxiety." This patent describes compositions and methods for treating depressive and anxiety disorders in subjects in need of such treatment. A therapeutically effective amount of a composition comprising a melanocortin 5 receptor (MC5R) peptide ligand is administered to the subject. The MC5R peptide acts as a selective MC5R antagonist, which can lead to clinical improvement in treating these disorders in a relatively short time. Another notable patent is for "Methods for the treatment of depression and anxiety by a melanocortin 5 receptor antagonist, PG-20N." This patent outlines methods for treating depressive and anxiety disorders by administering a therapeutically effective amount of a composition comprising PG-20N.
Career Highlights
Throughout his career, Morgan has worked with prestigious institutions such as the University of Arizona and the Texas A&M University System. His research has focused on developing effective treatments for mental health conditions, showcasing his dedication to improving patient outcomes.
Collaborations
Morgan has collaborated with notable colleagues, including Victor J. Hruby and Minying Cai. These partnerships have contributed to the advancement of his research and the development of innovative treatment methods.
Conclusion
Caurnel Morgan's contributions to the field of mental health through his patents and collaborations highlight his commitment to innovation in treatment. His work continues to pave the way for new approaches to addressing depression and anxiety disorders.